Additional information
Off white Powder
546-57-6
ACI-052309
(1S,4S,5R,8R,9S,10S,11R,12R,14R)-5-ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one (Erythralosamine),
(1S,4S,5R,8R,9S,10S,11R,12R,14R)-5-ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one (erythralosamine),
199.2-201.1°C
C29H49NO8
539.7
Ambient
2-8°C
3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)-10,11-didehydro-9-deoxo-6,11,12-trideoxy-6,9:9,12-diepoxy-erythromycin; 6,15,16-Trioxatricyclo[10.2.1.11,4]hexadecane Erythromycin Derivative
Antibiotic






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)